YOLFTbeta
Picard Medical, Inc.

Picard Medical, Inc.

PMI · AMEX · Healthcare / Medical Devices

7.23USD-0.62 (-7.90%)

Price History

Full chart

Market Stats

Previous Close7.85
Open8.00
Day Range6.25 – 8.00
52-Week Range2.65 – 684.00
Volume56.51K
Market Cap10.80M
P/E (TTM)0.00
Forward P/E0.00
EPS-35.81
Dividend Yield0.00%
50-Day Avg5.02
200-Day Avg40.00

About

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Yuncai Fang Ph.D.
  • Employees75
  • Headquarters1992 East Silverlake Road, Tucson, AZ, United States, 85713, USA
  • Websitehttps://www.picardmedical.com

Leadership

  • Dr. Yuncai Fang Ph.D.Interim CEO & Chairman of the Board · b. 1966
  • Mr. Matthew SchusterChief Operating Officer · b. 1981
  • Ms. Georgina SmithChief Accounting Officer · b. 1972
  • Dr. Frank Tinker Ph.D.Chief Technology Officer of SynCardia Systems, LLC · b. 1956

Financials

Income Statement

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Revenue4.11M5.04M4.39M4.94M
Growth (%)-+22.61%-12.93%+12.50%
Cost of Revenue9.10M7.35M4.50M4.74M
Gross Profit-4.99M-2.31M-112.00K200.00K
Gross Margin-121.27%-45.83%-2.55%4.05%
Operating Expense6.08M13.19M13.60M13.00M
Operating Income-11.07M-15.50M-13.71M-12.80M
Operating Margin-269.07%-307.40%-312.28%-259.11%
EBITDA-10.61M-14.85M-17.46M-26.49M
EBITDA Margin-257.89%-294.39%-397.63%-536.19%
Net Income-11.17M-15.57M-21.05M-27.00M
Net Income Margin-271.53%-308.72%-479.50%-546.56%
R&D1.90M2.21M3.38M3.00M
R&D as % of Total Revenue46.24%43.88%76.98%60.73%
Interest Expense5.00K140.00K3.07M5.39M
Interest Expense % of Total Revenue0.12%2.78%69.85%109.17%

Balance Sheet

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Assets15.44M11.37M12.11M22.55M
Total Liabilities4.07M14.93M35.84M18.76M
Total Equity11.37M-3.55M-23.74M3.79M
Cash152.00K244.00K96.00K7.45M
Total Debt1.96M9.41M20.93M6.97M
Net Debt1.81M9.17M20.83M-476.00K

Cash Flow

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.72M-10.63M-11.87M-15.67M
Investing Cash Flow-37.00K-9.00K0-
Financing Cash Flow5.52M10.84M11.74M27.08M
Capital Expenditure29.00K7.00K00
Free Cash Flow-10.75M-10.64M-11.87M-15.67M
FCF to OCF100.27%100.07%100.00%100.00%

Earnings

Report DateJul 14, 2025Nov 14, 2025Mar 31, 2026May 15, 2026Aug 19, 2026Nov 13, 2026
EPS Estimate0.00----1.50-1.50
EPS Actual-0.80-0.19-0.06-0.10-1.33-
Surprise----11.33%-
Timing-After-hoursAfter-hoursAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap10.80M
Enterprise Value12.18M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.72
Price / Book6.20
EPS-35.81
Book Value0.835
Revenue (TTM)6.30M
Gross Profit (TTM)1.17M
EBITDA-15.46M
Profit Margin0.00%
Operating Margin-156.70%
Return on Equity0.00%
Return on Assets-93.61%
Shares Outstanding2.34M
Shares Float1.28M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 3, 20261:50